Raymond M. Jordt - Jan 31, 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Business Officer
Signature
/s/ Greg Weaver as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Jan 31, 2025
Transactions value $
$13,541
Form type
4
Date filed
2/3/2025, 08:45 PM
Previous filing
Jan 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $13.5K +2.61K +8.1% $5.18 34.9K Jan 31, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 1, 2024.